DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Aktueller Standort:
>
> This Story


Log in oder Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Business Affairs Homepage

IBM to pay $14.8 million to settle Maryland false claims allegations Settlement revolved around the 2011 acquisition by IBM of Cúram Software

Change Healthcare's IPO now heading beyond $1 billion Offering 49 million shares at $19 each

Silicon Valley investor paints dire picture for future of radiologists Claims they should no longer exist in a decade

Installing and removing imaging equipment is no small task Expert insights on how project management is evolving

Canon, Toshiba each hit with $2.5 million fine over acquisition deal Deal violated premerger notification and waiting period requirements

GE likely to hold onto NY digital X-ray detector manufacturing plant — for now New York State facility employs 125 workers

Ohio radiology services president indicted in Medicare scam Charged for services never provided and received nearly $2 million

Half of radiologists have net worth of $2 million or more New survey analyzed responses from over 20,000 physicians in over 30 specialties

Getting ahead of the digital health avalanche How can a health system know which innovative tools are worth its time?

Varian to acquire Cancer Treatment Services International for $283 million Enables production of multidisciplinary solutions

Siemens' push to install Atellica systems may hurt full-year profits

by Thomas Dworetzky , Contributing Reporter
Siemens Healthineers AG's growth “clearly accelerated in the second quarter of the current fiscal year 2019,” the company said in a statement, but the push to speed installations of its Atellica Solution machines did put pressure on year-long profit margins.

Revenue for Siemens Healthineers was up 5.8 percent from the year-ago quarter and hit 3.5 billion euros, driven by the Imaging and Advanced Therapies segments, with EMEA and China seeing substantial growth.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



"The positive volume and profit development in the last quarter underscores the important progress we have made in achieving our full-year targets,” Bernd Montag, CEO of Siemens Healthineers AG, said in a statement as the company's Q2 results were announced. He also stressed that, “the Imaging and Advanced Therapies businesses in particular have again demonstrated their leading global positions. The measures taken to ensure a successful market launch of our laboratory diagnostics platform Atellica Solution have shown an early impact in the second quarter.”

The Imaging segment saw revenues rising to 2.1 billion euros in the quarter, a seven percent increase from the year-ago quarter. “Molecular Imaging, Computed Tomography and X-Ray Products showed a strong development,” added the company, advising that, “the Imaging segment’s adjusted profit margin rose to 21 percent, mainly due to higher revenue and cost savings. Profitability thus remained within the midterm target range of 20 to 22 percent.”

The Diagnostics segment’s adjusted profit margin hit 11.8 percent — but was “negatively impacted by currency effects and ramp-up costs for Atellica Solution,” according to the statement. Ramp up included the shipping of more than 410 Atellica Solution analyzers the quarter ended March 31, making a total of more than 780 shipped in the first six months.

The Advanced Therapies segment set a record with revenues of 391 euros in Q2, up about nine percent from the year-ago quarter. And adjusted profit margin hit 19.6 percent, thanks to a boost in revenue and cost-savings.

The speed of the ramp-up will bring down the divisions profits for the year, but the push is hoped to help the company take market share from leader Roche, according to Reuters.

Market share gains occurred in all imaging businesses, noted Montag, according to Reuters.

The company is holding to its fiscal 2019 outlook, anticipating revenue growth to be in the four-to-five percent range over 2018, with adjusted profit margin of 17.5 to 18.5 percent and earnings forecast to hit 20 to 30 percent over FY 2018.
  Pages: 1 - 2 >>

Business Affairs Homepage


You Must Be Logged In To Post A Comment

E-Mail-Werbung
Erhöhen Sie Ihren Bekanntheitsgrad
Auktionen + Privatverkäufe
Den besten Preis erzielen
Geräte/Geräteteile kaufen
Den günstigsten Preis finden
Daily News
Die neuesten Nachrichten lesen
Übersicht
Alle DOTmed Benutzer durchsuchen
Ethik auf DOTmed
Unseren Ethik-Standard anzeigen
Gold-Parts Verkäufer-Programm
PH-Anfragen erhalten
Gold Service Dealer-Programm
Anfragen empfangen
Gesundheitsdienstleister
Alle Gesundheitsdienstleister-Tools anzeigen
Jobs/Training
Einen Job suchen
Parts Hunter +EasyPay
Angebote für Geräteteile erhalten
Kürzlich zertifizierte Benutzer anzeigen
Kürzlich zertifizierte Benutzer anzeigen
Kürzlich auf DOTmed bewertet
Kürzlich zertifizierte Benutzer anzeigen
Rental Central
Geräte billiger mieten
Geräte/Geräteteile verkaufen
Das meiste Geld erhalten
Servicetechniker
Hilfe und Beratung finden
Einfache Angebots-Anfrage
Angebote für Geräte erhalten
Virtuelle Messe
Service für Geräte finden
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED